Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

36.16
-0.2500-0.69%
Pre-market: 36.570.4100+1.13%05:32 EDT
Volume:2.27M
Turnover:81.23M
Market Cap:3.49B
PE:-7.68
High:36.41
Open:36.13
Low:35.06
Close:36.41
52wk High:72.66
52wk Low:35.06
Shares:96.64M
Float Shares:95.45M
Volume Ratio:0.94
T/O Rate:2.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7061
EPS(LYR):-4.3646
ROE:-43.62%
ROA:-28.02%
PB:2.81
PE(LYR):-8.28

Loading ...

Xenon Pharmaceuticals Coverage Assumed by Guggenheim at Buy

Dow Jones
·
Oct 06

Xenon Pharmaceuticals assumed with a Buy at Guggenheim

TIPRANKS
·
Oct 06

Xenon Grants 17,850 Inducement Stock Options, 10,500 RSUs to New Hires Under NASDAQ Rule

Reuters
·
Oct 03

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Oct 03

Xenon's AZK Approval Path Unlikely to Be Hurt by Safety Issues, RBC Says

MT Newswires Live
·
Oct 01

Xenon Pharma CEO Ian Mortimer Acquires $1,121,400 in Common Shares

Reuters
·
Oct 01

Defence Therapeutics Appoints Ex-Xenon CFO Sherry Aulin to Board, Audit Committee

Reuters
·
Sep 29

Xenon Pharmaceuticals Inc. : Jefferies Cuts Target Price to $90 from $100

THOMSON REUTERS
·
Sep 28

Xenon Pharmaceuticals Presents at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit Fireside Chat

Reuters
·
Sep 22

US Stocks-S&P 500, NASDAQ Advance, Turning the Page on a Tumultuous Week

Reuters
·
Sep 19

U.S. Small Caps Close Lower; Xenon Pharmaceuticals Posts Biggest Loss

Dow Jones
·
Sep 19

Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE)

TIPRANKS
·
Sep 19

U.S. Stocks on the MOVE-Halozyme Therapeutics, Etsy, Netflix

Reuters
·
Sep 18

Xenon Pharmaceuticals' Azetukalner Retains Core Epilepsy Value, RBC Capital Markets Says

MT Newswires Live
·
Sep 18

Xenon Pharmaceuticals Down over 28%, on Pace for Largest Percent Decrease Since March 2017

Dow Jones
·
Sep 18

Xenon Pharmaceuticals falls -29.8%

TIPRANKS
·
Sep 18

Netflix Down 6% On Wells Fargo Downgrade; Xenon Halts Depression Drug Trial Enrollment On Side-Effect Concerns, Shares Plunge 22%

Tiger Newspress
·
Sep 18

Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday as Tech Rally Continues

MT Newswires Live
·
Sep 18

U.S. Stocks on the MOVE-CoreWeave, StubHub, Ultragenyx

Reuters
·
Sep 18

Sector Update: Healthcare

MT Newswires Live
·
Sep 18